EUCODIS Bioscience Relocates to Campus Vienna Biocenter
Vienna, Europe, September 1, 2009 – EUCODIS Bioscience, a company developing, manufacturing, and marketing enzymes and other proteins for the chemical industry, announced today that it has relocated to its new premises on Campus Vienna Biocenter. The Campus VBC is Austria’s largest life sciences center. It is home to leading biotechnology companies and research organizations, with more than 1,700 researchers on site.
“The Campus VBC is a thriving life sciences hub that offers state-of-the-art infrastructure to EUCODIS Bioscience,” said Rudy Pandjaitan, PhD, CEO of EUCODIS Bioscience. “Our new premises at Campus VBC are perfectly suited for the needs of a growing organization: Earlier this year we have successfully launched our first product, and we are in the process of launching further enzymes. Therefore we are expanding our manufacturing capacity, and we also expect our marketing and sales activities to grow accordingly.”
About EUCODIS Bioscience
EUCODIS Bioscience GmbH develops, manufactures, and markets industrial enzymes.
EUCODIS Bioscience’ products help customers in the chemical, pharmaceutical, and food and feed industries to make manufacturing processes more efficient and cleaner, and to generate products with superior properties.
EUCODIS Bioscience originally focused on developing enzymes for industrial partners, including GlaxoSmithKline, Henkel, and Lohmann Animal Health. Since 2009, the Company also markets its own products.
Led by an experienced management team, EUCODIS Bioscience is backed by Austrian and German institutional venture capital funds, founders, and private investors. The Company is headquartered in Austria, Europe, with subsidiaries in France and Germany.
For more information, please visit www.eucodisbioscience.com
Company contact EUCODIS Bioscience:
Rudy Pandjaitan, PhD
Campus Vienna Biocenter II
Viehmarktgasse 2 a/ 2. OG
Media contact EUCODIS Bioscience:
Investor Relations & Communications